Plain-English translation of NCT05215197 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Cochlear implants are devices that help people with severe hearing loss hear sounds. Over time, scar tissue can build up around the implant and make it less effective. This study tests whether applying platelet-rich fibrin—a natural substance made from your own blood that reduces inflammation—during implant surgery can slow down or prevent this scarring and keep the implant working better for longer.
The biggest problem with cochlear implants is that they often become less effective over time because of scar tissue buildup inside the ear. Researchers want to see if this treatment can prevent that scarring and help implants continue working well for years to come.
You likely qualify if…
You likely don't qualify if…
You would undergo cochlear implant surgery as you normally would. During the operation, the surgeon will apply the platelet-rich fibrin substance (made from your own blood) to the area where the implant is placed. After surgery, you'll have follow-up visits at 1 week, 1 month, 3 months, and 6 months where the research team will test how well your implant is working using standard electrical measurements.
AI-generated summary from trial data · Aug 26, 2026 · Not medical advice
Turkey (Türkiye)
Sponsor
Pamukkale University
Enrollment target
~10 participants
Started
January 2022
Primary completion
December 2028
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Fazil N Ardic, MD
Pamukkale University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.